Trials / Conditions / Acute Myeloid Leukemia Recurrent
Acute Myeloid Leukemia Recurrent
4 registered clinical trials studyying Acute Myeloid Leukemia Recurrent — 3 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | CIML NK Cells With Venetoclax for AML NCT06152809 | Dana-Farber Cancer Institute | Phase 1 |
| Recruiting | A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, V NCT05735184 | Kura Oncology, Inc. | Phase 1 |
| Unknown | Allogenic CD123-CAR-NK Cells in the Treatment of Refractory/Relapsed Acute Myeloid Leukemia NCT05574608 | Affiliated Hospital to Academy of Military Medical Sciences | EARLY_Phase 1 |
| Recruiting | CLAG-GO for Patients With Persistent, Relapsed or Refractory AML NCT04050280 | University of Maryland, Baltimore | Phase 2 |